Abstract:Objective To study the effect of Naloxone combined with Edaravone on the treatment of acute cerebral hemorrhage and the level of plasma fibrinogen (FIB) and D-Dimer (D-D). Methods Totally 150 patients with acute cerebral hemorrhage in our hospital from March 2015 to March 2017 were randomly divided into study group and control group with prospective study (75 cases in each group). The control group was treated with surgery. The study group was treated with extra Naloxone combined with Edaravone apart from surgery. Fourteen days after treatment,total effective rate, incidence of adverse reactions, serum inflammatory factors, serum oxidative stress products, plasma FIG and D-D levels were compared between the two groups, as well as NIHSS and Fugl-Meyer scores pre- and posttreatment. Results Total effective rate of the treatment group was 90.67%, which was higher than the control group (P < 0.05); levels of plasma FIB, Fugl-Meyer scores of the study group were higher than the control group (P < 0.05);the NIHSS score, serum inflammatory factors, serum oxidative stress and the level of D-D in the study group were lower than the control group (P < 0.05). Conclusions Naloxone combined with Edaravone can be effective in the treatment of acute cerebral hemorrhage, reduce the serum inflammatory cytokines and levels of oxidative stress products and improve the coagulation function, which shows a positive effect on patients with neurological function.